BIOMAT Database Logo BIOMAT Database Logo

Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response. 1998

F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29403, USA.

BACKGROUND Major depressive disorder (MDD) in the adolescent demonstrates a unique clinical profile, and pathogenic serotonergic dysregulation is hypothesized. Parenteral clomipramine (CMI) is known to distinguish adult MDD from control, but neurochallenge data are lacking in adolescent MDD. METHODS Thirteen drug-free outpatient adolescents who met DSM-III-R criteria for MDD were compared to adolescent controls by acute neuroendocrine and mood response to 12.5 mg of parenteral CMI. RESULTS Repeated measures analysis revealed significant changes from baseline for sadness (p < .01) between groups, with normal controls increasing sadness rating after CMI. Prolactin (PRL) maximum change score from baseline was decreased in MDD relative to controls (p < .05). Gender effects on PRL were evident in controls but not in MDD. CONCLUSIONS The findings of PRL blunting in adolescent MDD mirrors previous work in adults. A unique finding is the induction of sadness in normal adolescent controls after CMI infusion.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D009490 Neurosecretory Systems A system of NEURONS that has the specialized function to produce and secrete HORMONES, and that constitutes, in whole or in part, an ENDOCRINE SYSTEM or organ. Neuroendocrine System,Neuroendocrine Systems,Neurosecretory System,System, Neuroendocrine,System, Neurosecretory,Systems, Neuroendocrine,Systems, Neurosecretory
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002997 Clomipramine A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine. Chlorimipramine,Anafranil,Chlomipramine,Clomipramine Hydrochloride,Clomipramine Maleate (1:1),Clomipramine Monohydrochloride,Hydiphen,Hydrochloride, Clomipramine,Monohydrochloride, Clomipramine
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
January 1990, Psychiatry research,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Pulse clomipramine for depressed adolescents.
July 1998, The American journal of psychiatry,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
March 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Dissociable hormonal, cognitive, and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
May 2003, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
September 1992, The American journal of psychiatry,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Perceived social inadequacy and depressed mood in adolescents.
June 2002, Journal of adolescence,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis.
January 2009, Depression and anxiety,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
January 1980, Postgraduate medical journal,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children.
November 1992, Archives of general psychiatry,
F R Sallee, and N S Vrindavanam, and D Deas-Nesmith, and A M Odom, and S W Carson, and G Sethuraman
Neuroendocrine response to trihexyphenidyl in depressed patients.
February 1992, Clinical neuropharmacology,
Copied contents to your clipboard!